Ovidrel (Serono SA)
Ovidrel (Serono SA) Brand names, Ovidrel (Serono SA) Analogs
Ovidrel (Serono SA) Brand Names Mixture
- No information avaliable
Ovidrel (Serono SA) Chemical_Formula
C1105H1770N318O336S26
Ovidrel (Serono SA) RX_link
http://www.rxlist.com/cgi/generic/ovidrel.htm
Ovidrel (Serono SA) fda sheet
Ovidrel (Serono SA) msds (material safety sheet)
Ovidrel (Serono SA) Synthesis Reference
No information avaliable
Ovidrel (Serono SA) Molecular Weight
25719.7
Ovidrel (Serono SA) Melting Point
55 oC (Forastieri, H., Ingham, K.C. J. Biol. Chem. 257:7976-7981 (1982))
Ovidrel (Serono SA) H2O Solubility
No information avaliable
Ovidrel (Serono SA) State
Solid
Ovidrel (Serono SA) LogP
-0.258
Ovidrel (Serono SA) Dosage Forms
Solution (Subcutaneous Injection)
Ovidrel (Serono SA) Indication
For the treatment of female infertility
Ovidrel (Serono SA) Pharmacology
Choriogonadotropin alfa is used to treat female infertility, Choriogonadotropin alfa stimulates late follicular maturation and resumption of oocyte meiosis, and initiates rupture of the pre-ovulatory ovarian follicle. Ovidrel is an analogue of Luteinizing Hormone (LH) and binds to the LH/hCG receptor of the granulosa and theca cells of the ovary to effect these changes in the absence of an endogenous LH surge.
Ovidrel (Serono SA) Absorption
No information avaliable
Ovidrel (Serono SA) side effects and Toxicity
No information avaliable
Ovidrel (Serono SA) Patient Information
No information avaliable
Ovidrel (Serono SA) Organisms Affected
Humans and other mammals
